(GM) General Motors - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US37045V1008
Stock: Vehicles, Parts, Financing, Software
Total Rating 50
Risk 65
Buy Signal 0.12
| Risk 5d forecast | |
|---|---|
| Volatility | 36.5% |
| Relative Tail Risk | -14.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.63 |
| Alpha | 49.61 |
| Character TTM | |
|---|---|
| Beta | 0.949 |
| Beta Downside | 0.708 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.02% |
| CAGR/Max DD | 0.79 |
EPS (Earnings per Share)
Revenue
Description: GM General Motors March 05, 2026
General Motors (GM) is an American automotive manufacturer. They design, build, and sell a range of vehicles and parts globally.
GM operates through three segments: GM North America, GM International, and GM Financial. The company utilizes a multi-brand strategy, including Buick, Cadillac, Chevrolet, and GMC. This is common in the automotive industry to target diverse consumer segments.
Sales channels include retail dealers, distributors, and direct sales to fleet customers such as rental car companies and government entities. GM also provides after-sale services, including maintenance and repairs, which represent a recurring revenue stream for automotive companies.
The company offers automotive financing and software-enabled services. These services provide additional revenue streams beyond vehicle sales. For deeper insights into GMs financial performance, consider exploring ValueRays detailed analyses.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 3.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 6.07 > 1.0 |
| NWC/Revenue: 8.34% < 20% (prev 6.55%; Δ 1.79% < -1%) |
| CFO/TA 0.10 > 3% & CFO 26.87b > Net Income 3.31b |
| Net Debt (109.33b) to EBITDA (18.82b): 5.81 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (919.4m) vs 12m ago -18.63% < -2% |
| Gross Margin: 6.27% > 18% (prev 0.12%; Δ 614.3% > 0.5%) |
| Asset Turnover: 65.96% > 50% (prev 67.00%; Δ -1.04% > 0%) |
| Interest Coverage Ratio: 3.79 > 6 (EBITDA TTM 18.82b / Interest Expense TTM 1.12b) |
Altman Z'' 1.26
| A: 0.05 (Total Current Assets 108.77b - Total Current Liabilities 93.34b) / Total Assets 281.28b |
| B: 0.18 (Retained Earnings 51.52b / Total Assets 281.28b) |
| C: 0.02 (EBIT TTM 4.24b / Avg Total Assets 280.52b) |
| D: 0.19 (Book Value of Equity 41.19b / Total Liabilities 218.12b) |
| Altman-Z'' Score: 1.26 = BB |
Beneish M -2.20
| DSRI: 1.03 (Receivables 13.05b/12.83b, Revenue 185.02b/187.44b) |
| GMI: 1.99 (GM 6.27% / 12.49%) |
| AQI: 0.99 (AQ_t 0.31 / AQ_t-1 0.31) |
| SGI: 0.99 (Revenue 185.02b / 187.44b) |
| TATA: -0.08 (NI 3.31b - CFO 26.87b) / TA 281.28b) |
| Beneish M-Score: -2.20 (Cap -4..+1) = BB |
What is the price of GM shares?
As of March 05, 2026, the stock is trading at USD 78.60 with a total of 6,341,466 shares traded.
Over the past week, the price has changed by -4.65%, over one month by -8.91%, over three months by +4.60% and over the past year by +75.62%.
Over the past week, the price has changed by -4.65%, over one month by -8.91%, over three months by +4.60% and over the past year by +75.62%.
Is GM a buy, sell or hold?
General Motors has received a consensus analysts rating of 3.66.
Therefor, it is recommend to hold GM.
- StrongBuy: 9
- Buy: 5
- Hold: 12
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the GM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 94.6 | 20.4% |
| Analysts Target Price | 94.6 | 20.4% |
GM Fundamental Data Overview February 28, 2026
P/E Trailing = 24.7064
P/E Forward = 6.3331
P/S = 0.4073
P/B = 1.1949
P/EG = 3.5983
Revenue TTM = 185.02b USD
EBIT TTM = 4.24b USD
EBITDA TTM = 18.82b USD
Long Term Debt = 94.61b USD (from longTermDebt, last quarter)
Short Term Debt = 35.67b USD (from shortTermDebt, last quarter)
Debt = 130.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 109.33b USD (from netDebt column, last quarter)
Enterprise Value = 184.70b USD (75.37b + Debt 130.28b - CCE 20.95b)
Interest Coverage Ratio = 3.79 (Ebit TTM 4.24b / Interest Expense TTM 1.12b)
EV/FCF = 16.68x (Enterprise Value 184.70b / FCF TTM 11.07b)
FCF Yield = 6.00% (FCF TTM 11.07b / Enterprise Value 184.70b)
FCF Margin = 5.99% (FCF TTM 11.07b / Revenue TTM 185.02b)
Net Margin = 1.79% (Net Income TTM 3.31b / Revenue TTM 185.02b)
Gross Margin = 6.27% ((Revenue TTM 185.02b - Cost of Revenue TTM 173.42b) / Revenue TTM)
Gross Margin QoQ = -2.48% (prev 6.41%)
Tobins Q-Ratio = 0.66 (Enterprise Value 184.70b / Total Assets 281.28b)
Interest Expense / Debt = 0.43% (Interest Expense 559.0m / Debt 130.28b)
Taxrate = 10.84% (338.0m / 3.12b)
NOPAT = 3.78b (EBIT 4.24b * (1 - 10.84%))
Current Ratio = 1.17 (Total Current Assets 108.77b / Total Current Liabilities 93.34b)
Debt / Equity = 2.13 (Debt 130.28b / totalStockholderEquity, last quarter 61.12b)
Debt / EBITDA = 5.81 (Net Debt 109.33b / EBITDA 18.82b)
Debt / FCF = 9.87 (Net Debt 109.33b / FCF TTM 11.07b)
Total Stockholder Equity = 64.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.18% (Net Income 3.31b / Total Assets 281.28b)
RoE = 5.13% (Net Income TTM 3.31b / Total Stockholder Equity 64.56b)
RoCE = 2.66% (EBIT 4.24b / Capital Employed (Equity 64.56b + L.T.Debt 94.61b))
RoIC = 1.91% (NOPAT 3.78b / Invested Capital 197.35b)
WACC = 3.69% (E(75.37b)/V(205.64b) * Re(9.41%) + D(130.28b)/V(205.64b) * Rd(0.43%) * (1-Tc(0.11)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -16.09%
[DCF] Terminal Value 80.82% ; FCFF base≈11.07b ; Y1≈7.27b ; Y5≈3.32b
[DCF] Fair Price = N/A (negative equity: EV 105.68b - Net Debt 109.33b = -3.65b; debt exceeds intrinsic value)
EPS Correlation: 45.02 | EPS CAGR: 5.00% | SUE: 1.26 | # QB: 2
Revenue Correlation: 79.74 | Revenue CAGR: 6.33% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.32 | Chg7d=-0.030 | Chg30d=+0.203 | Revisions Net=+8 | Analysts=18
EPS current Year (2026-12-31): EPS=12.44 | Chg7d=-0.048 | Chg30d=+0.596 | Revisions Net=+14 | Growth EPS=+17.4% | Growth Revenue=+0.5%
EPS next Year (2027-12-31): EPS=13.87 | Chg7d=+0.070 | Chg30d=+0.755 | Revisions Net=+13 | Growth EPS=+11.5% | Growth Revenue=+2.3%
[Analyst] Revisions Ratio: +1.00 (8 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 9.4% - Earnings Yield 4.0%)
[Growth] Growth Spread = -4.7% (Analyst 0.7% - Implied 5.4%)
P/E Forward = 6.3331
P/S = 0.4073
P/B = 1.1949
P/EG = 3.5983
Revenue TTM = 185.02b USD
EBIT TTM = 4.24b USD
EBITDA TTM = 18.82b USD
Long Term Debt = 94.61b USD (from longTermDebt, last quarter)
Short Term Debt = 35.67b USD (from shortTermDebt, last quarter)
Debt = 130.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 109.33b USD (from netDebt column, last quarter)
Enterprise Value = 184.70b USD (75.37b + Debt 130.28b - CCE 20.95b)
Interest Coverage Ratio = 3.79 (Ebit TTM 4.24b / Interest Expense TTM 1.12b)
EV/FCF = 16.68x (Enterprise Value 184.70b / FCF TTM 11.07b)
FCF Yield = 6.00% (FCF TTM 11.07b / Enterprise Value 184.70b)
FCF Margin = 5.99% (FCF TTM 11.07b / Revenue TTM 185.02b)
Net Margin = 1.79% (Net Income TTM 3.31b / Revenue TTM 185.02b)
Gross Margin = 6.27% ((Revenue TTM 185.02b - Cost of Revenue TTM 173.42b) / Revenue TTM)
Gross Margin QoQ = -2.48% (prev 6.41%)
Tobins Q-Ratio = 0.66 (Enterprise Value 184.70b / Total Assets 281.28b)
Interest Expense / Debt = 0.43% (Interest Expense 559.0m / Debt 130.28b)
Taxrate = 10.84% (338.0m / 3.12b)
NOPAT = 3.78b (EBIT 4.24b * (1 - 10.84%))
Current Ratio = 1.17 (Total Current Assets 108.77b / Total Current Liabilities 93.34b)
Debt / Equity = 2.13 (Debt 130.28b / totalStockholderEquity, last quarter 61.12b)
Debt / EBITDA = 5.81 (Net Debt 109.33b / EBITDA 18.82b)
Debt / FCF = 9.87 (Net Debt 109.33b / FCF TTM 11.07b)
Total Stockholder Equity = 64.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.18% (Net Income 3.31b / Total Assets 281.28b)
RoE = 5.13% (Net Income TTM 3.31b / Total Stockholder Equity 64.56b)
RoCE = 2.66% (EBIT 4.24b / Capital Employed (Equity 64.56b + L.T.Debt 94.61b))
RoIC = 1.91% (NOPAT 3.78b / Invested Capital 197.35b)
WACC = 3.69% (E(75.37b)/V(205.64b) * Re(9.41%) + D(130.28b)/V(205.64b) * Rd(0.43%) * (1-Tc(0.11)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -16.09%
[DCF] Terminal Value 80.82% ; FCFF base≈11.07b ; Y1≈7.27b ; Y5≈3.32b
[DCF] Fair Price = N/A (negative equity: EV 105.68b - Net Debt 109.33b = -3.65b; debt exceeds intrinsic value)
EPS Correlation: 45.02 | EPS CAGR: 5.00% | SUE: 1.26 | # QB: 2
Revenue Correlation: 79.74 | Revenue CAGR: 6.33% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.32 | Chg7d=-0.030 | Chg30d=+0.203 | Revisions Net=+8 | Analysts=18
EPS current Year (2026-12-31): EPS=12.44 | Chg7d=-0.048 | Chg30d=+0.596 | Revisions Net=+14 | Growth EPS=+17.4% | Growth Revenue=+0.5%
EPS next Year (2027-12-31): EPS=13.87 | Chg7d=+0.070 | Chg30d=+0.755 | Revisions Net=+13 | Growth EPS=+11.5% | Growth Revenue=+2.3%
[Analyst] Revisions Ratio: +1.00 (8 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 9.4% - Earnings Yield 4.0%)
[Growth] Growth Spread = -4.7% (Analyst 0.7% - Implied 5.4%)